Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Huszthy PC"'
Publikováno v:
Cellular and Molecular Immunology.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Haghmorad D; Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran., Oksenych V; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway., Huszthy PC; Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 04; Vol. 15, pp. 1434684. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).
Autor:
Tesfaye DY; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway., Bobic S; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway., Lysén A; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway., Huszthy PC; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Center for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway., Gudjonsson A; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway., Braathen R; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway., Bogen B; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway.; Center for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway., Fossum E; Department of Immunology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Kristian Gerhard Jebsen Center for Research on Influenza Vaccines, University of Oslo and Oslo University Hospital, Oslo, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Feb 28; Vol. 13, pp. 752714. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).
Autor:
Szodoray P; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: peter.szodoray@medisin.uio.no., Andersen TK; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for Influenza Vaccine Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Heinzelbecker J; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Imbery JF; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Huszthy PC; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway., Stanford SM; Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, 9500 Gilman Drive MC #0656, La Jolla, CA 92093, USA., Bogen B; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for Influenza Vaccine Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Landsverk OB; Department of Pathology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway., Bottini N; Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, 9500 Gilman Drive MC #0656, La Jolla, CA 92093, USA., Tveita A; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Munthe LA; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Nakken B; Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway; K.G. Jebsen Center for B Cell Malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Cell reports [Cell Rep] 2021 Aug 10; Vol. 36 (6), pp. 109525.
Autor:
Huszthy PC; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; peter.csaba.huszthy@rr-research.no bjarne.bogen@medisin.uio.no.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Gopalakrishnan RP; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Jacobsen JT; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY 10065., Haabeth OAW; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305., Løset GÅ; Department of Biosciences, University of Oslo, N-0316 Oslo, Norway.; Nextera AS, N-0349 Oslo, Norway., Braathen R; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; KG Jebsen Centre for Research on Influenza Vaccines, Institute of Clinical Medicine, University of Oslo, N-0316 Oslo, Norway., Schenck K; Institute of Oral Biology, Faculty of Dentistry, University of Oslo, N-0316 Oslo, Norway., Tveita AA; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, N-0316 Oslo, Norway., Munthe LA; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, N-0316 Oslo, Norway., Bogen B; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway; peter.csaba.huszthy@rr-research.no bjarne.bogen@medisin.uio.no.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; KG Jebsen Centre for Research on Influenza Vaccines, Institute of Clinical Medicine, University of Oslo, N-0316 Oslo, Norway.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Dec 17; Vol. 116 (51), pp. 25850-25859. Date of Electronic Publication: 2019 Dec 03.
Autor:
Exner ND; Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; University of Applied Sciences Mittweida, Department of Applied Informatics & Biosciences, Mittweida, Germany., Valenzuela JAC; Institut für Medizinische Informatik und Biometrie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Abou-El-Ardat K; Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Miletic H; Department of Pathology, Haukeland University Hospital, Bergen, Norway.; Department of Biomedicine, University of Bergen, Bergen, Norway., Huszthy PC; Oslo University Hospital-Rikshospitalet, Department of Immunology, Oslo, Norway., Radehaus PM; University of Applied Sciences Mittweida, Department of Applied Informatics & Biosciences, Mittweida, Germany., Schröck E; Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Molecular Tumor Diagnostics, National Center for Tumor Diseases (NCT), Dresden, Germany., Bjerkvig R; Department of Biomedicine, University of Bergen, Bergen, Norway.; Oncology Department, Luxembourg Institute of Health, Val Fleuri, Luxembourg., Kaderali L; University Medicine Greifswald, Institute of Bioinformatics, Greifswald, Germany., Klink B; Institut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Molecular Tumor Diagnostics, National Center for Tumor Diseases (NCT), Dresden, Germany.; Centre national de Génétique, Laboratoire National de Santé, Dudelange, Luxembourg.; Co-senior authors., Nigro JM; Department of Biomedicine, University of Bergen, Bergen, Norway.; Co-senior authors.
Publikováno v:
Oncotarget [Oncotarget] 2019 Jun 04; Vol. 10 (38), pp. 3641-3653. Date of Electronic Publication: 2019 Jun 04 (Print Publication: 2019).